| Dose-response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction R Mohebi, Y Liu, IL Piña, MF Prescott, J Butler, GM Felker, JH Ward, ... Journal of the American College of Cardiology 80 (16), 1529-1541, 2022 | 22 | 2022 |
| Lipoprotein (a), oxidized phospholipids, and coronary artery disease severity and outcomes TC Gilliland, Y Liu, R Mohebi, H Miksenas, S Haidermota, M Wong, X Hu, ... Journal of the American College of Cardiology 81 (18), 1780-1792, 2023 | 20 | 2023 |
| Association between sacubitril/valsartan initiation and mitral regurgitation severity in heart failure with reduced ejection fraction: the PROVE-HF study JL Januzzi, AMS Omar, Y Liu, S Murphy, J Butler, GM Felker, IL Piña, ... Circulation 146 (21), 1638-1640, 2022 | 14 | 2022 |
| Impact of moderate aortic stenosis in patients with heart failure with reduced ejection fraction KR Khan, OA Khan, C Chen, Y Liu, RR Kandanelly, PJ Jamiel, ... Journal of the American College of Cardiology 81 (13), 1235-1244, 2023 | 9 | 2023 |
| Inflammation across universal definition of heart failure stages: the CASABLANCA study R Mohebi, Y Liu, R van Kimmenade, HK Gaggin, SP Murphy, ... European Journal of Heart Failure 25 (2), 152-160, 2023 | 7 | 2023 |
| Coronary computed tomographic angiography with fractional flow reserve in patients with type 2 myocardial infarction CP McCarthy, SP Murphy, DK Amponsah, PK Rambarat, C Lin, Y Liu, ... Journal of the American College of Cardiology 82 (17), 1676-1687, 2023 | 5 | 2023 |
| Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial JL Januzzi, R Mohebi, Y Liu, N Sattar, HJL Heerspink, E Tefera, ... Circulation 148 (8), 651-660, 2023 | 4 | 2023 |
| Prediction of left ventricular ejection fraction change following treatment with sacubitril/valsartan R Mohebi, Y Liu, GM Felker, MF Prescott, IL Piña, J Butler, JH Ward, ... Heart Failure 11 (1), 44-54, 2023 | 4 | 2023 |
| Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial R Mohebi, Y Liu, MK Hansen, Y Yavin, N Sattar, CA Pollock, J Butler, ... Cardiovascular Diabetology 22 (1), 176, 2023 | 3 | 2023 |
| Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial JL Januzzi, S Del Prato, J Rosenstock, J Butler, J Ezekowitz, NE Ibrahim, ... Cardiovascular Diabetology 23 (1), 49, 2024 | 2 | 2024 |
| Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan PL Myhre, Y Liu, IJ Kulac, BL Claggett, MF Prescott, GM Felker, J Butler, ... European Journal of Heart Failure 25 (8), 1396-1405, 2023 | 2 | 2023 |
| Isovolumic contraction velocity in heart failure with reduced ejection fraction and effect of sacubitril/valsartan: the PROVE-HF study AMS Omar, S Murphy, GM Felker, I Piña, J Butler, Y Liu, R Mohebi, ... Journal of Cardiac Failure 30 (5), 653-665, 2024 | 1 | 2024 |
| Sex differences in coronary artery disease characteristics among patients with type 2 myocardial infarction C Lin, CP McCarthy, R Mohebi, Y Liu, R Blankstein, SP Murphy, ... JACC: Advances 3 (2), 100795, 2024 | 1 | 2024 |
| Race-Free Creatinine-Based Estimation of GFR and Projection of CKD to 2060 in the United States R Mohebi, J Coresh, DC Crews, MM Estrella, AS Levey, Y Liu, ... Clinical Journal of the American Society of Nephrology 18 (11), 1476-1478, 2023 | 1 | 2023 |
| Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan R Mohebi, Y Liu, PL Myhre, GM Felker, MF Prescott, IL Piña, J Butler, ... Heart Failure 11 (7), 855-858, 2023 | 1 | 2023 |
| Heart failure duration and mechanistic efficacy of sacubitril/valsartan in heart failure with reduced ejection fraction R Mohebi, Y Liu, GM Felker, MF Prescott, JH Ward, IL Pina, J Butler, ... Journal of Cardiac Failure 28 (12), 1673-1682, 2022 | 1 | 2022 |
| Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events MS Khan, JL Januzzi Jr, Y Liu, J Xu, W Shaw, N Sattar, KW Mahaffey, ... Journal of Cardiac Failure, 2024 | | 2024 |
| Vascular Endothelial Growth Factors and Risk of Cardio-renal Events: Results from the CREDENCE trial JL Januzzi Jr, Y Liu, N Sattar, Y Yavin, CA Pollock, J Butler, M Jardine, ... American Heart Journal, 2024 | | 2024 |
| Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points R Mohebi, Y Liu, MK Hansen, Y Yavin, N Sattar, CA Pollock, J Butler, ... Clinical Journal of the American Society of Nephrology, 10.2215, 2023 | | 2023 |
| Sex Differences in Coronary Artery Disease Characteristics Among Patients With Type 2 Myocardial Infarction: Results From the Prospective DEFINE-Type 2 MI Study C Lin, CP McCarthy, R Mohebi, Y Liu, R Blankstein, C Rogers, S Hedgire, ... Circulation 148 (Suppl_1), A11776-A11776, 2023 | | 2023 |
